We also evaluated the expression levels of the epithelial marker E- cadherin, N-cadherin, SNAI2, CD44, and vimentin in treated U87 and U251 cells to examine whether EMT is regulated by ZBC260 in glioma cells. Here, CD44 is linked to central nervous system cancer.